INTRODUCTION: Aim of this study was to evaluate the use of @entity2850 ( @entity2850 ) in the prevention of symptomatic @entity1211 ( @entity1211 ) in @entity1 undergoing esophagectomy for @entity5 . METHODS: From a prospective database, all @entity1 operated between 2010 and 2014 received @entity2850 in addition to LMWH and were compared to a historical cohort of @entity1 treated LMWH only (2004-2009). RESULTS: Of the 313 included @entity1 , 195 (62%) received @entity2850 . @entity1 with @entity2850 received neoadjuvant chemoradiation more often (45% vs. 3%, P   <   0.001), whereas, neoadjuvant chemotherapy was equally distributed (31% vs. 34%, P   =   0.631). There were no differences with regard to surgical approach, operative time, @entity190 , and ICU stay. @entity1 treated without @entity2850 had a longer hospital stay (18 vs. 15 days, P   =   0.014). Overall, 12 clinical @entity1211 's occurred in 11 @entity1 , which consisted of two @entity1150 and 10 @entity1151 . In the group of @entity1 , who received @entity2850 1.5% developed a symptomatic @entity1211 compared to 6.8% in @entity1 without @entity2850 (OR   =   0.215; 95% CI   =   0.06-0.83). Multivariate analysis identified @entity2850 as the only independent prognostic factor correlated with a reduction in postoperative @entity1211 's (OR   =   0.225; 95% CI   =   0.06-0.88). CONCLUSION: The addition of @entity2850 in @entity1 undergoing esophagectomy for @entity5 was associated with a reduction in symptomatic @entity1211 's. J. Surg. Oncol. 2017;115:181-185.    2017 Wiley Periodicals, Inc.

Intermittent pneumatic compression in combination with low-molecular weight heparin in the prevention of XXXX in esophageal cancer surgery.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity190 :: ('MESH:D006473', 'Disease') :: ['blood loss'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer'] @entity2850 :: ('MESH:D009408', 'Disease') :: ['Intermittent Pneumatic Compression', 'IPC'] @entity1150 :: ('MESH:D020246', 'Disease') :: ['deep venous thromboses'] @entity1151 :: ('MESH:D011655', 'Disease') :: ['pulmonary embolisms'] @entity1211 :: ('MESH:D054556', 'Disease') :: ['VTE', 'venous thromboembolic events']
@entity1211 :: (MESH:D054556,Disease) :: ['venous thromboembolic events']
